Source:http://linkedlifedata.com/resource/pubmed/id/17579223
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
23
|
| pubmed:dateCreated |
2007-6-20
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1538-3598
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
20
|
| pubmed:volume |
297
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2581; author reply 2582
|
| pubmed:meshHeading |
pubmed-meshheading:17579223-Adenocarcinoma,
pubmed-meshheading:17579223-Antimetabolites, Antineoplastic,
pubmed-meshheading:17579223-Chemotherapy, Adjuvant,
pubmed-meshheading:17579223-Deoxycytidine,
pubmed-meshheading:17579223-Humans,
pubmed-meshheading:17579223-Pancreatic Neoplasms,
pubmed-meshheading:17579223-Survival Analysis
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
|
| pubmed:publicationType |
Letter,
Comment
|